Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: ChinuSFO who wrote (13173)	8/12/1998 8:19:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

Just thought I would offer this old post from a satisfied MUSE patient who was smart enough to know that Viagra was not a safe drug: Message 2039019

To: ChinuSFO who wrote (13173)	8/12/1998 8:30:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

CR, With the average daily volume dropping dramatically lately (about 1/2 million) it will take the short interest about a month to cover. But if they attempt to cover in a week or so, they will quickly pop the price above 10 again. Good news to look forward to: 1)An increase of new script numbers thus signaling a significant uptrend. 2)Announcement of a strong domestic partner. 3)announcement of new countries approving MUSE in Q3, including Canada with a $2,000,000.00 milestone payment. 4)Viagra safety issues continue to be mentioned by experts in cardiology and opthamology which is a big plus for the MUSE safety profile. The short interest appears to have become complacent about covering but within 2 months they will regret that they did not cash in their chips and take their manipulative powers elsewhere.